title: [Meningitis caused by Enterococcus faecalis during disseminated anguilluliasis].
abstract: BACKGROUND
  Disseminated anguilluliasis is a serious disease requiring early diagnosis and treatment. The occurrence of bacterial complications, especially meningeal, is generally due to Gram-negative bacteria from the gastrointestinal tract.
  
  
  METHODS
  A 52-year-old man from Guadeloupe, treated for T-lymphoma during the previous year by polychemotherapy, was hospitalized for meningitis. Culture of the cerebrospinal fluid and the bronchoalveolar lavage both showed Enterococcus faecalis. Strongyloides stercoralis were also found in the stool and bronchoalveolar lavage. Outcome under treatment was favorable.
  
  
  CONCLUSIONS
  This case reminds us of the usefulness of presumptive routine ivermectin treatment for all patients exposed to any immunosuppression treatment and ever having lived in a tropical area and thus possibly infected by chronic but silent anguilluliasis, even in the absence of parasitological certainty.
authors.affiliation: Service de réanimation polyvalente, Institut Gustave Roussy, Villejuif. jean-ralph.zahar@nck.ap-hop-paris.fr
authors.forename: Jean-Ralph
authors.initials: JR
authors.lastname: Zahar
authors.forename: Jacques
authors.initials: J
authors.lastname: Tankovic
authors.forename: Emilie
authors.initials: E
authors.lastname: Catherinot
authors.forename: Patrick
authors.initials: P
authors.lastname: Meshaka
authors.forename: Gérard
authors.initials: G
authors.lastname: Nitenberg
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000977:Antiparasitic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid; D002555:Cerebrospinal Fluid / Q000382:microbiology; D004359:Drug Therapy, Combination; D013293:Enterococcus faecalis / Q000302:isolation & purification; D005243:Feces / Q000469:parasitology; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D016920:Meningitis, Bacterial / Q000150:complications / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged; D017171:Strongyloides stercoralis / Q000302:isolation & purification; D013322:Strongyloidiasis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000469:parasitology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000977:Antiparasitic Agents; D005839:Gentamicins; D007559:Ivermectin; D000658:Amoxicillin